Radiation: 1,109 Real Stories

1,109 stories match radiation. 868 of them mention chemotherapy.

Cancer Stories

Edie, who was diagnosed with Stage III Colorectal CancerColorectal Cancer

Edie: Stage III Colorectal Cancer

Patient Info: Edie, Female, 50s | Stage III

As of March 2025, Edie had recovered after chemotherapy, radiation, lower anterior resection, temporary ileostomy, and reversal; lymph nodes were negative, margins were clean, and follow-up scans and colonoscopies had remained clear.

The Patient Story
OutcomeCancer-Free / NED
A patient, who was diagnosed with Breast CancerBreast Cancer

Breast cancer history: atypical pelvic fracture after long-term zoledronic acid

Patient Info: Anonymized, Female, 60s | Stage Metastatic/Advanced

Prior breast cancer treatment had been completed; CT during fracture evaluation showed no metastatic disease, and the atypical iliac wing fracture healed progressively with conservative care and teriparatide.

PubMed Central
OutcomeSurvivorship / Completed Treatment
A patient, who was diagnosed with Stage IV Small Cell Lung CancerLung Cancer

EGFR-Mutant Lung Adenocarcinoma That Transformed to Small Cell Lung Cancer

Patient Info: Anonymized, female, 40s | Stage IV

Biomarkers: EGFR exon 19 deletion; acquired EGFR T790M mutation

Metastatic Site: liver

The cancer progressed after transformation to small cell lung cancer, and she died 49 months after the original diagnosis.

PubMed Central
OutcomeIn Memory
A patient, who was diagnosed with Stage IV Small Cell Lung CancerLung Cancer

EGFR-Mutant Lung Adenocarcinoma That Transformed to Small Cell Lung Cancer

Patient Info: Anonymized, female, 40s | Stage IV

Biomarkers: EGFR exon 19 deletion

Metastatic Site: brain, adrenal gland, liver, thyroid

The cancer progressed after small-cell transformation with adrenal, thyroid, liver and brain involvement, and she died 52.7 months after the original diagnosis from disease progression and organ failure.

PubMed Central
OutcomeIn Memory
Katie, who was diagnosed with Stage III Invasive Lobular CarcinomaBreast Cancer

Stage III HR-Positive Invasive Lobular Carcinoma: Katie's Patient Story

Patient Info: Katie, Female, Under 40 | Stage III

Biomarkers: ER-positive; PR-positive; HER2-negative; genetic testing negative

As of February 2025, Katie was a few months beyond active treatment for Stage III ER-positive, PR-positive, HER2-negative ILC and was adjusting to maintenance therapy with Verzenio, Lupron, and Letrozole.

Lobular Breast Cancer Alliance
OutcomeCare Ongoing
Edie, who was diagnosed with Stage III Colorectal CancerColorectal Cancer

Stage III Colorectal Cancer: Edie's Survivor Story

Patient Info: Edie, Female, 50s | Stage III

After total neoadjuvant treatment, lower anterior resection, and ileostomy reversal, Edie reported clear scans/colonoscopies and described herself as a colon cancer survivor. As of February 2025, she remained in survivorship.

The Patient Story
OutcomeCancer-Free / NED
Chance, who was diagnosed with Stage II Breast CancerBreast Cancer

Facing Triple-Negative Breast Cancer: Chance’s Story

Patient Info: Chance, Female, Under 40 | Stage II

Biomarkers: ER-negative; PR-negative; HER2-negative; BRCA1 mutation

As of February 2025, Chance described follow-up after Stage II BRCA1-associated triple-negative breast cancer and stated that she did not currently have cancer, while continuing close surveillance.

The Patient Story
OutcomeCancer-Free / NED
Kelly, who was diagnosed with Stage III Breast CancerBreast Cancer

Stage III Triple-Negative Breast Cancer: Kelly's Survivor Story

Patient Info: Kelly, Female, Under 40 | Stage III

Biomarkers: Triple-negative breast cancer; no inherited cancer gene mutation found.

As of February 2025, Kelly identified as a Stage IIIC triple-negative breast cancer survivor after neoadjuvant chemotherapy, double mastectomy with reconstruction, and radiation, and was using her experience to support others through TNBC Thrivers.

The Patient Story
OutcomeSurvivorship / Completed Treatment
Denelle, who was diagnosed with Stage III Colorectal CancerColorectal Cancer

Stage III Colorectal Cancer: Denelle's Survivor Story

Patient Info: Denelle, Female | Stage III

As of February 2025, Denelle had a complete response to total neoadjuvant therapy for Stage IIIB rectal cancer, avoided surgery, and was in active surveillance with scans and scopes every 3 months.

The Patient Story
OutcomeCancer-Free / NED
Brian, who was diagnosed with Small Cell Lung CancerLung Cancer

Small Cell Lung Cancer: Brian's Patient Story

Patient Info: Brian, Male, 40s

As of February 2025, Brian was actively receiving chemotherapy and twice-daily radiation for limited-stage small cell lung cancer and remained hopeful during treatment.

The Patient Story
OutcomeCare Ongoing
Brian, who was diagnosed with Stage III Small Cell Lung CancerLung Cancer

Stage III Small Cell Lung Cancer: Brian's Patient Story

Patient Info: Brian, Male | Stage III

Brian was early in treatment for Stage III limited-stage small cell lung cancer. As of February 2025, he had completed 1 round of chemotherapy, was starting concurrent radiation, and was waiting on PET scan results to assess response or spread.

The Patient Story
OutcomeCare Ongoing
Denelle, who was diagnosed with Stage III Colorectal CancerColorectal Cancer

Stage III Colorectal Cancer: Denelle's Patient Story

Patient Info: Denelle Chapman, Female | Stage III

After chemoradiation and systemic chemotherapy for Stage IIIB rectal cancer, Mayo Clinic scans showed a complete response midway through chemotherapy. As of February 2025, she was finishing treatment and entering surveillance rather than immediate surgery.

The Patient Story
OutcomeResponding Well
A patient, who was diagnosed with Lung AdenocarcinomaLung Cancer

Treating Lung Adenocarcinoma Alongside a Separate Esophageal Cancer

Patient Info: Anonymized, male, 60s

Biomarkers: PD-L1 negative; ALK negative; no mutations detected on lung-cancer testing

By July 2024, the lung lesion remained in partial response and he was alive 36 months after the synchronous cancer diagnoses, eating well and gaining weight.

PubMed Central
OutcomeResponding Well
A patient, who was diagnosed with Stage IV Invasive Ductal CarcinomaBreast Cancer

Metastatic Breast Cancer Returning About 20 Years After Initial Treatment

Patient Info: Anonymized, Female | Stage IV

Biomarkers: ER-positive, PR-negative, HER2-positive

Metastatic Site: bones

About 20 years after her original breast-cancer treatment and sustained remission, bone biopsy confirmed metastatic recurrence; she became too unwell for planned cancer therapy and chose supportive care.

PubMed Central
OutcomeSetback / Progression
Evan, who was diagnosed with Stage IV Colorectal CancerColorectal Cancer

Stage IV Colorectal Cancer: Evan's Patient Story

Patient Info: Evan White, Male, Under 40 | Stage IV

Metastatic Site: lungs

After 1 year with no evidence of disease, Evan developed colorectal recurrence and later lung metastases; he died in October 2021 after about 4 years with cancer.

Fight Colorectal Cancer
OutcomeIn Memory
Wendy, who was diagnosed with Stage III Colorectal CancerColorectal Cancer

Stage III Colorectal Cancer: Wendy's Survivor Story

Patient Info: Wendy Harpp, Female, 50s | Stage III

Wendy completed multimodal treatment in 2020 and later became an active colorectal-cancer advocate; current surveillance results and recurrence status were not reported.

Fight Colorectal Cancer
OutcomeSurvivorship / Completed Treatment
A patient, who was diagnosed with Breast CancerBreast Cancer

Breast cancer survivor with synchronous intercostal nerve schwannomas mimicking metastasis

Patient Info: Anonymized, Female, Under 40

Biomarkers: Breast cancer biomarkers not reported; schwannomas were S100-positive

After prior breast cancer treatment, later D6-D7/rib lesions were proven to be S100-positive schwannomas rather than metastases, and surgical removal relieved the patient’s rib-cage numbness and pain.

PubMed Central
OutcomeSurvivorship / Completed Treatment
A patient, who was diagnosed with Stage IV Breast CancerBreast Cancer

Stage 4 hormone receptor-positive breast cancer: remission with PARP inhibitor

Patient Info: Anonymized, Female, 40s | Stage IV

Biomarkers: HR-positive breast cancer with HER2-low/negative recurrence, and pathogenic BRCA2 R2318* mutation.

Metastatic Site: pleura

As of January 2025, she had maintained complete response for 36 months after sequential FEC/docetaxel and olaparib for hormone receptor-positive, HER2-negative/HER2-low metastatic breast cancer with BRCA2 R2318* mutation.

PubMed Central
OutcomeCancer-Free / NED
A patient, who was diagnosed with Stage IV Small Cell Lung CancerLung Cancer

ALK-Fusion Small Cell Lung Cancer Responding to ALK-Targeted Therapy

Patient Info: Anonymized, female, 40s | Stage IV

Biomarkers: EML4-ALK fusion

Metastatic Site: brain

After several earlier treatments stopped controlling the cancer, ALK-targeted iruplinalkib produced a partial response and was still controlling disease after more than 8 months.

PubMed Central
OutcomeResponding Well
Tracy, who was diagnosed with Stage II Colorectal CancerColorectal Cancer

Stage II Colorectal Cancer: Tracy's Survivor Story

Patient Info: Tracy, Female, 40s | Stage II

As of February 2025, Tracy was in post-treatment survivorship after Stage IIB colorectal cancer treated with 28 days of Xeloda chemoradiation, colostomy surgery in December 2015, and discontinued post-surgery chemotherapy.

The Patient Story
OutcomeSurvivorship / Completed Treatment